Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: Low dose FRα vaccine|DRUG: Cyclophosphamide|BIOLOGICAL: High dose FRα vaccine
Sponsor: Marker Therapeutics, Inc.